{"registry_intelligence":{"schema_version":"alpha-registry-intelligence-v1","record_version":"unavailable","subject":"alpha:company:bridgebio-oncology-therapeutics-inc","as_of":"unavailable","recorded_at":"unavailable","availability":"unavailable","records":[],"next_offset":null,"limitations":["Structured intelligence is not currently available. Existing published profile evidence remains accessible."]},"protocol_version":"0.1","schema_version":"alpha.governance.entity.public.v1","record_version":"public-1","entity":{"id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","type":"Company","slug":"bridgebio-oncology-therapeutics-inc","canonical_url":"https://registry.alpha.ac/companies/bridgebio-oncology-therapeutics-inc","legal_name":"BridgeBio Oncology Therapeutics, Inc.","display_name":"BridgeBio Oncology Therapeutics, Inc.","aliases":[]},"publication":{"state":"PUBLISHED","published_at":"2026-10-04T04:46:28.768589+00:00","observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":"2026-10-04T04:46:28.768589+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":20,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/bridgebio-oncology-therapeutics-inc","media_type":"text/html"},"markdown":{"href":"https://registry.alpha.ac/companies/bridgebio-oncology-therapeutics-inc.md","media_type":"text/markdown"},"json":{"href":"https://registry.alpha.ac/api/public/companies/bridgebio-oncology-therapeutics-inc?format=record","media_type":"application/json"},"jsonld":{"href":"https://registry.alpha.ac/api/public/companies/bridgebio-oncology-therapeutics-inc?format=jsonld","media_type":"application/ld+json"},"api":{"href":"https://registry.alpha.ac/api/public/companies/bridgebio-oncology-therapeutics-inc","media_type":"application/json"},"mcp":{"uri":"alpha://companies/bridgebio-oncology-therapeutics-inc","endpoint":"https://mcp.alpha.ac/mcp","media_type":"application/json"}},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":20,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":5,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":20,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":20,"corroborated_claims":0,"sources":5,"distinct_sources":2,"role_claims":0,"last_reviewed_at":"2026-10-04T04:46:28.768589+00:00","observed_at":"2026-10-04T04:46:28.768589+00:00","freshness_days":0}},"claims":[{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:legal_name:1","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"BridgeBio Oncology Therapeutics, Inc.","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"BridgeBio Oncology Therapeutics, Inc.","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:87582eedadb599856a8197a9c2de0a573ea2932544dd0c541e1efedcdfa8c23c","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bridgebio-oncology-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-04T04:46:28.768589+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:entity_status:3","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:87582eedadb599856a8197a9c2de0a573ea2932544dd0c541e1efedcdfa8c23c","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bridgebio-oncology-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-04T04:46:28.768589+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:published_fact:4","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:87582eedadb599856a8197a9c2de0a573ea2932544dd0c541e1efedcdfa8c23c","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bridgebio-oncology-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-04T04:46:28.768589+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:5","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jake-bauer-bbot","object_label":null,"object_source_name_forms":[],"value":"Jake Bauer: Chairman of the Board","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Jake Bauer: Chairman of the Board","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:6","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:bihua-chen-m-b-a","object_label":null,"object_source_name_forms":[],"value":"Bihua Chen, M.B.A.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Bihua Chen, M.B.A.: Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:7","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:frank-p-mccormick-ph-d-f-r-s-d-sc-bridgebio-oncology-therapeutics-inc","object_label":null,"object_source_name_forms":[],"value":"Frank P. McCormick, Ph.D., F.R.S., D.Sc.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Frank P. McCormick, Ph.D., F.R.S., D.Sc.: Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:8","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michelle-doig-bbot","object_label":null,"object_source_name_forms":[],"value":"Michelle Doig: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Michelle Doig: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:4fb2caaa7b87f699564646847e39507307d10c4510786336f3cacd28be8b7dc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A d133143ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:08:37.701537+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:9","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:neil-kumar-bbot","object_label":null,"object_source_name_forms":[],"value":"Neil Kumar: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Neil Kumar: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:4fb2caaa7b87f699564646847e39507307d10c4510786336f3cacd28be8b7dc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A d133143ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:08:37.701537+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:10","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:neil-kumar-ph-d","object_label":null,"object_source_name_forms":[],"value":"Neil Kumar, Ph.D.: Executive Chairman of the Board","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Neil Kumar, Ph.D.: Executive Chairman of the Board","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:11","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:pedro-j-beltran-ph-d","object_label":null,"object_source_name_forms":[],"value":"Pedro J. Beltran, Ph.D.: Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Pedro J. Beltran, Ph.D.: Chief Executive Officer and Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:12","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:peter-lebowitz-bbot","object_label":null,"object_source_name_forms":[],"value":"Peter Lebowitz: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Peter Lebowitz: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:4fb2caaa7b87f699564646847e39507307d10c4510786336f3cacd28be8b7dc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A d133143ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:08:37.701537+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:13","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:peter-lebowitz-m-d-ph-d-bridgebio-oncology-therapeutics-inc","object_label":null,"object_source_name_forms":[],"value":"Peter Lebowitz, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Peter Lebowitz, M.D., Ph.D.: Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:14","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:praveen-tipirneni-m-d-m-b-a-bridgebio-oncology-therapeutics-inc","object_label":null,"object_source_name_forms":[],"value":"Praveen Tipirneni, M.D., M.B.A.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Praveen Tipirneni, M.D., M.B.A.: Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:15","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:raymond-kelleher-bbot","object_label":null,"object_source_name_forms":[],"value":"Raymond Kelleher: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Raymond Kelleher: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:4fb2caaa7b87f699564646847e39507307d10c4510786336f3cacd28be8b7dc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A d133143ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:08:37.701537+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:16","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:raymond-kelleher-m-d-ph-d-bridgebio-oncology-therapeutics-inc","object_label":null,"object_source_name_forms":[],"value":"Raymond Kelleher, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Raymond Kelleher, M.D., Ph.D.: Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:17","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:eli-wallace-ph-d","object_label":null,"object_source_name_forms":[],"value":"Eli Wallace, Ph.D.: Chief Executive Officer and President","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Eli Wallace, Ph.D.: Chief Executive Officer and President","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:8b2303f36f6ec815a7666e8fbf6d2fa62a3ea6eec91c90ebbafc8c675b1d6834","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BBOT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-15T23:21:14.882162+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:18","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:idan-elmelech-bridgebio-oncology-therapeutics-inc","object_label":null,"object_source_name_forms":[],"value":"Idan Elmelech: Chief Operating Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Idan Elmelech: Chief Operating Officer","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:19","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:pedro-j-beltran-ph-d","object_label":null,"object_source_name_forms":[],"value":"Pedro J. Beltran, Ph.D.: Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Pedro J. Beltran, Ph.D.: Chief Executive Officer","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:20","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:uneek-mehra","object_label":null,"object_source_name_forms":[],"value":"Uneek Mehra: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Uneek Mehra: Chief Financial Officer","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:623cc5b73fa680065bca4d0583ebe97802a3965a3751f6a2d519839572b90204","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BBOT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-15T23:21:15.461031+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:21","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:yong-ben-m-d-m-b-a","object_label":null,"object_source_name_forms":[],"value":"Yong Ben, M.D., M.B.A.: Chief Medical and Development Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Yong Ben, M.D., M.B.A.: Chief Medical and Development Officer","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-04T04:46:28.768589+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-04T04:46:28.768589+00:00","reviewed_at":"2026-10-04T04:46:28.768589+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"}],"evidence":[{"id":"alpha:projection-evidence:87582eedadb599856a8197a9c2de0a573ea2932544dd0c541e1efedcdfa8c23c","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bridgebio-oncology-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-04T04:46:28.768589+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:4fb2caaa7b87f699564646847e39507307d10c4510786336f3cacd28be8b7dc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A d133143ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:08:37.701537+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:8b2303f36f6ec815a7666e8fbf6d2fa62a3ea6eec91c90ebbafc8c675b1d6834","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BBOT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-15T23:21:14.882162+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:623cc5b73fa680065bca4d0583ebe97802a3965a3751f6a2d519839572b90204","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BBOT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-15T23:21:15.461031+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage":{"identity":"PUBLISHED","business":"PUBLISHED","leadership":"PUBLISHED","board_and_committees":"PUBLISHED","governance":"NOT_ASSERTED","financials":"NOT_ASSERTED","workforce":"NOT_ASSERTED","ownership":"NOT_ASSERTED","ratings":"NOT_PUBLISHED","market_and_index_context":"PUBLISHED"},"representation_version":"alpha-governance-record-v2","role_modules":[],"attention":[],"committee_data":[],"quality":{"schema_version":"alpha-record-quality-v1","overall":0.86,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.903,"cross_source_agreement":0.75},"diagnostics":{"published_claims":20,"factual_claims":20,"claims_with_linked_evidence":20,"disputed_claims":0,"stale_claims":0,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"]},"derivation":"deterministic_record_projection"}}